Matthew Weston
Matthew Weston is an analyst at UBS, known for his insights into the pharmaceutical sector. Recently, he published a study highlighting the rapid market penetration of generics following the expiration of patents for major Novartis medications, forecasting significant impacts on the company's revenue from these changes.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Matthew Weston is an analyst who indicated that the estimates for Entresto's sales might be overly optimistic.
5